Ritmoforine Retard 250 mg
As listed in the register: Ritmoforine Retard 250 mg, tabletten met gereguleerde afgifte
250 mg · tablet met gereguleerde afgifte
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Disopyramidediwaterstoffosfaat
- Made by
- CHEPLAPHARM Arzneimittel GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | CHEPLAPHARM Arzneimittel GmbH |
|---|---|
| Active substance | Disopyramidediwaterstoffosfaat |
| Used in | Heart, blood pressure and circulation |
| Strength | 250 mg |
| Form | tablet met gereguleerde afgifte |
| Classification | C01BA03 · Heart, blood pressure and circulation |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Ritmoforine Retard 250 mg, tabletten met gereguleerde afgifte |
| RVG | 08613 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).